Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HPRT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LAMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSNAX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHOQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETNK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRRC2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TTTY1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GOSR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPFIA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LIG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGS14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RECK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on